LIC decreased its stake in Pfizer Limited from 3.85% to 3.74%, selling 52,069 shares. The transaction was valued at ₹25.42 Cr at a share price of ₹4881.50.
A multinational pharmaceutical manufacturer engaged in producing, marketing, trading, and exporting medicines across India through both owned facilities and contract manufacturers positioned nationwide. The company distributes its products via independent distributors and maintains a significant presence in the domestic pharmaceutical market. Its operations span multiple therapeutic areas serving healthcare needs across the country.
India's largest domestic institutional investor with over Rs 56 lakh crore in total AUM, of which roughly Rs 15 lakh crore sits in listed equities. Holds stakes in virtually every major listed Indian company. When LIC builds or exits a position, it moves markets. Government-owned and mandated to invest policyholder funds in Indian equities and bonds, making it the ultimate long-only, long-term India bull.
